1 Stock Under $65 That You Shouldn’t Ignore

Leading biopharmaceutical company Gilead Sciences (GILD) reported impressive sales in the last quarter and raised its full-year 2022 guidance. Furthermore, the company’s strategic acquisitions, drug approvals, and research breakthroughs should drive its growth in the coming quarters. Given GILD’s discounted valuation, we think it could be wise to buy this stock at the current attractive…

Learn to Code Online, In Your Own Time

Disclosure: Our goal is to feature products and services that we think you’ll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from our commerce partners. Being an entrepreneur is being committed to learning new skills to help your company thrive into the future.…

1 Stock That Is a Hard Pass for the Smart Investor

Shares of fintech company Affirm Holdings (AFRM) have plummeted more than 75% in price year-to-date. The company has been dealing with economic and credit cycle headwinds, which impacted its financials. Its profitability is expected to be significantly affected by shrinking consumer spending. Hence, we think investors should stay away from this stock. Continue reading…. shutterstock.com…